A AddLife AB
A
Open
142.4 -6.13
Overzicht
Wijziging aandelenprijs
24u
Min
142.4
Max
146.5
Inkomsten | 179M 260M |
|---|---|
Verkoop | 304M 2.7B |
K/W Sectorgemiddelde | 31.438 86.001 |
EPS | 1.15 |
Dividendrendement | 0.99 |
Winstmarge | 9.513 |
Werknemers | 2,319 |
EBITDA | 238M 602M |
Dividendrendement Sectorgemiddelde | 0.99% 2.73% |
|---|
Marktkapitalisatie | 999M 18B |
|---|---|
Vorige openingsprijs | 148.53 |
Vorige sluitingsprijs | 142.4 |
AddLife AB Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
AddLife AB Prognose
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
